Details of the Drug Formulations

General Information of Drug (ID: DMECBWN)

Drug Name
Riluzole Drug Info
Synonyms
Rilutek; Riluzol; Riluzolum; Riluzole HCl; RP 54274; ALBB-006046; BF-37; PK-26124; R-116; RP-54274; Rilutek (TN); Riluzol [INN-Spanish]; Riluzole [USAN:INN]; Riluzolum [INN-Latin]; ZERO/001785; Amino-2 trifluoromethoxy-6 benzothiazole; Amino-2 trifluoromethoxy-6 benzothiazole [French]; Riluzole (JAN/USAN/INN); PK-26124, RP-54274, Rilutek, Riluzole; 2-Amino-6-(trifluoromethoxy)-benzothiazole; 2-Amino-6-(trifluoromethoxy)benzothiazole; 2-Amino-6-trifluoro-methoxybenzothiazole; 2-amino-6-(trifluoromethoxy)-1,3-benzothiazole; 2-amino-6-(trifluoromethoxy)benzo[d]thiazole; 2-amino-6-(trifluoromethoxyl)benzothiazole; 2-amino-6-trifluoromethoxybenzothiazole; 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine; 6-(trifluoromethoxy)benzo[d]thiazol-2-amine; 6-Trifluoromethoxy-benzothiazol-2-ylamine; 6-trifluoromethoxybenzothiazole-2-yl-amine
Indication
Disease Entry ICD 11 Status REF
Amyotrophic lateral sclerosis 8B60.0 Approved [1]
Therapeutic Class
Anticonvulsants
Cross-matching ID
PubChem CID
5070
ChEBI ID
CHEBI:8863
CAS Number
1744-22-5
TTD ID
D0H0KB
VARIDT ID
DR00205
INTEDE ID
DR1425
ACDINA ID
D00595

Full List of Drug Formulations Containing This Drug

Riluzole 50 mg tablet
Company Formulation ID FDA Description
Ascend Laboratories; Kaiser Foundation Hospitals F19003 Magnesium stearate; Dibasic calcium phosphate dihydrate; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 400; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
AvKARE; Rising Pharmaceuticals F19004 Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 6000; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Hypromelloses
Kaiser Foundation Hospitals; Sun Pharmaceutical Industries F18997 Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Povidone k30; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
Mylan Pharamceuticals F18998 Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
Glenmark Pharmaceutials F18999 Magnesium stearate; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
American Health Packaging F19000 Magnesium stearate; Calcium phosphate, dibasic, dihydrate; Talc; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
Global Pharmaceuticals F19001 Magnesium stearate; Talc; Titanium dioxide; Triacetin; Croscarmellose sodium; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols
Apotex F19002 Magnesium stearate; Dibasic calcium phosphate dihydrate; Talc; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Hypromellose 2910 (6 mpa.s); Polyethylene glycol 8000
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Formulation(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2326).